0001293973-13-000001.txt : 20130305
0001293973-13-000001.hdr.sgml : 20130305
20130305183859
ACCESSION NUMBER: 0001293973-13-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130301
FILED AS OF DATE: 20130305
DATE AS OF CHANGE: 20130305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ehrlich Christopher B
CENTRAL INDEX KEY: 0001293973
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51934
FILM NUMBER: 13667603
MAIL ADDRESS:
STREET 1: C/O INTERWEST PARTNERS
STREET 2: 2710 SAND HILL ROAD, 2ND FLOOR
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMIMETIC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001138400
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 621786244
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1211
BUSINESS ADDRESS:
STREET 1: 389-A NICHOL MILL LANE
CITY: FRANKLIN
STATE: TN
ZIP: 37067
BUSINESS PHONE: 615 844 1280
MAIL ADDRESS:
STREET 1: 389-A NICHOL MILL LANE
CITY: FRANKLIN
STATE: TN
ZIP: 37067
FORMER COMPANY:
FORMER CONFORMED NAME: BIOMIMETIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010413
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2013-03-01
1
0001138400
BIOMIMETIC THERAPEUTICS, INC.
BMTI
0001293973
Ehrlich Christopher B
C/O INTERWEST PARTNERS
2710 SAND HILL ROAD, 2ND FLOOR
MENLO PARK
CA
94025
1
0
0
0
Common Stock
2013-03-01
4
D
0
1250
D
0
D
Common Stock
2013-03-01
4
D
0
941177
D
0
I
By: InterWest Management Partners X, LLC
Common Stock
2013-03-01
4
D
0
857692
D
0
I
By: InterWest Management Partners VIII, LLC
Common Stock
2013-03-01
4
D
0
6846
D
0
I
By: InterWest Management Partners VIII, LLC
Common Stock
2013-03-01
4
D
0
24538
D
0
I
By: InterWest Management Partners VIII, LLC
Stock Option (right to buy)
17.09
2013-03-01
4
D
0
5831
0
D
2017-06-21
Common Stock
5831
0
D
Stock Option (right to buy)
11.64
2013-03-01
4
D
0
8840
0
D
2018-06-19
Common Stock
8840
0
D
Disposed of pursuant to the Agreement and Plan of Merger ("Merger Agreement") dated as of November 19, 2012, by and among the Company, Wright Medical Group, Inc. ("Wright"), Achilles Merger Subsidiary, Inc. and Achilles Acquisition Subsidiary, LLC in exchange for the following merger consideration per share of the Company's common stock: (a) $1.50 in cash, without interest; (b) 0.2482 of a share of Wright's common stock; and (c) one contingent value right ("CVR") issued by Wright.
The Reporting Person is a Member of InterWest Management Partners X, LLC, the General Partner of InterWest Partners X, LP ("IW10"). IW10 owns 941,177 shares of BMTI Common Stock. The Reporting Person disclaims beneficial ownership of the shares held by IW10 except to the extent of his pecuniary interest therein.
The Reporting Person is a Member of InterWest Management Partners VIII, LLC, the General Partner of InterWest Partners VIII, LP ("IW8"), InterWest Investors VIII, LP ("II8"), and InterWest Investors Q VIII, LP ("IIQ8"). IW8 owns 857,692 shares of BMTI Common Stock, II8 owns 6,846 shares of BMTI Common Stock, and IIQ8 owns 24,538 shares of BMTI Common Stock (together "The IW Fund Holdings"). The Reporting Person disclaims beneficial ownership of The IW Fund Holdings except to the extent of his pecuniary interest therein.
Option canceled. Pursuant to the Merger Agreement, the reporting person entered into an agreement with the issuer to terminate stock options with an exercise price greater than $13.00.
Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 4,613 shares of Wright common stock at an exercise price of $22.31 per share.
/s/ Christopher B. Ehrlich
2013-03-05